Jun Wang
Chief Executive Officer bij Shenzhen iCarbonX Technology Co., Ltd.
Vermogen: 195 M $ op 31-03-2024
Profiel
Als oprichter van Shenzhen Tanyun Intelligence Technology Co. Ltd., Jun Wang is momenteel Chief Executive Officer bij deze onderneming, Voorzitter van AOBiome LLC en Voorzitter voor BGI Biotech (Shenzhen) Co., Ltd. Dr. Wang zit ook in de raad van bestuur van PatientsLikeMe LLC en BGI Genomics Co., Ltd. (voormalig Chief Executive Officer). (voormalig Chief Executive Officer). Dr. Wang behaalde een bachelor en een doctoraat aan de Peking University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
30-09-2023 | 34 470 455 ( 8.39% ) | 195 M $ | 31-03-2024 |
Actieve functies van Jun Wang
Bedrijven | Functie | Begin |
---|---|---|
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | Chief Executive Officer | 20-10-2015 |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | Chairman | 31-05-2018 |
BGI Biotech (Shenzhen) Co., Ltd.
BGI Biotech (Shenzhen) Co., Ltd. BiotechnologyHealth Technology BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China. | Chairman | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Chairman | - |
Eerdere bekende functies van Jun Wang
Bedrijven | Functie | Einde |
---|---|---|
PatientsLikeMe LLC
PatientsLikeMe LLC Internet Software/ServicesTechnology Services PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA. | Director/Board Member | - |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Director/Board Member | - |
BGI GENOMICS CO., LTD. | Chief Executive Officer | - |
Opleiding van Jun Wang
Peking University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BGI GENOMICS CO., LTD. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
PatientsLikeMe LLC
PatientsLikeMe LLC Internet Software/ServicesTechnology Services PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA. | Technology Services |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Health Technology |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | Technology Services |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Health Technology |
BGI Biotech (Shenzhen) Co., Ltd.
BGI Biotech (Shenzhen) Co., Ltd. BiotechnologyHealth Technology BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China. | Health Technology |